Panorama Studios International Q3 2025 Financial Trend Analysis and Market Performance

Nov 18 2025 04:02 PM IST
share
Share Via
Panorama Studios International’s latest quarterly results for September 2025 reveal a marked shift in its financial trend parameter, moving from negative to very negative territory. The company’s revenue and profitability metrics for the quarter contrast sharply with its recent six-month performance and historical averages, signalling a significant adjustment in its financial evaluation.
Panorama Studios International Q3 2025 Financial Trend Analysis and Market Performance

In the latest quarter, Panorama Studios International reported net sales of ₹77.86 crores, reflecting a decline of 33.0% compared to the average of the previous four quarters. This contrasts with the six-month net sales figure of ₹214.21 crores, which shows a growth rate of 81.95%. The disparity between the quarterly and half-yearly sales figures indicates a recent contraction in sales momentum. Profit after tax (PAT) for the quarter stood at ₹2.04 crores, down by 81.2% relative to the preceding four-quarter average, underscoring pressure on the company’s bottom line.

Strong fundamentals, solid momentum, fair price – This Large Cap from the NBFC sector checks every box for our Top 1%. This should definitely be on your radar!

  • Complete fundamentals package
  • Technical momentum confirmed
  • Reasonable valuation entry

Add to Your Radar Now →

Operating profit before depreciation, interest and taxes (PBDIT) for the quarter was ₹3.73 crores, the lowest recorded in recent periods. The operating profit to net sales ratio also reached a low of 4.79%, indicating margin contraction. Interest expenses for the latest six months totalled ₹5.74 crores, with a growth rate of 21.61%, which, combined with operating profit to interest coverage of just 1.31 times for the quarter, highlights increased financial strain. Return on capital employed (ROCE) for the half-year was recorded at 20.34%, the lowest in recent history, while the debtors turnover ratio stood at 4.03 times, also at a low point.

Non-operating income for the quarter accounted for 219.48% of profit before tax (PBT), which itself was negative at ₹-1.84 crores excluding other income. Earnings per share (EPS) for the quarter was ₹0.27, the lowest in the recent four-quarter span. These figures collectively illustrate a challenging quarter for Panorama Studios International, with key profitability and efficiency metrics reflecting a downward adjustment in financial performance.

Panorama Studios International or something better? Our SwitchER feature analyzes this micro-cap Media & Entertainment stock and recommends superior alternatives based on fundamentals, momentum, and value!

  • SwitchER analysis complete
  • Superior alternatives found
  • Multi-parameter evaluation

See Smarter Alternatives →

From a market perspective, Panorama Studios International’s stock price closed at ₹178.95, slightly below the previous close of ₹179.70 on the day of reporting. The stock’s 52-week high and low are ₹244.95 and ₹152.00 respectively, with intraday trading ranging between ₹177.00 and ₹182.90. The stock’s short-term returns show a mixed picture: a weekly gain of 0.31% contrasts with a monthly decline of 9.89%. Year-to-date, the stock has recorded a negative return of 13.99%, while the Sensex benchmark has posted a positive return of 8.36% over the same period. Over longer horizons, Panorama Studios International’s returns have outpaced the Sensex, with a three-year return of 429.59% compared to Sensex’s 37.31%, and a five-year return of 1509.26% versus Sensex’s 91.65%.

These figures suggest that while the company has demonstrated strong long-term growth relative to the broader market, recent quarterly performance has prompted a revision in its financial trend evaluation. Investors and market participants may wish to consider these dynamics carefully when analysing Panorama Studios International’s current position within the Media & Entertainment sector.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
Saboo Sodium Chloro Ltd is Rated Sell
51 minutes ago
share
Share Via
Jenburkt Pharmaceuticals Ltd. is Rated Sell
51 minutes ago
share
Share Via
iStreet Network Ltd is Rated Sell
51 minutes ago
share
Share Via
Emmbi Industries Ltd is Rated Sell
51 minutes ago
share
Share Via
Cohance Lifesciences Ltd is Rated Sell
51 minutes ago
share
Share Via
Vivo Bio Tech Ltd. is Rated Strong Sell
51 minutes ago
share
Share Via